Frontiers In Oncology

Frontiers In Oncology

肿瘤学前沿

  • 3区 中科院分区
  • Q2 JCR分区

期刊简介

《Frontiers In Oncology》是由Frontiers Media S.A.出版社于2011年创办的英文国际期刊(ISSN: 2234-943X,E-ISSN: 2234-943X),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为Biochemistry, Genetics and Molecular Biology-Cancer Research。作为SCIE收录期刊(JCR分区 Q2,中科院 3区),本刊采用OA开放获取模式(OA占比1%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比73.21%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在4475篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Frontiers In Oncology审稿周期约为 14 Weeks 。该刊近年未被列入国际预警名单,年发文量约4475篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 4475 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 107 / 322

66.9%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 133 / 322

58.85%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:6.2 SJR:1.066 SNIP:0.831
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q2 120 / 404

70%

大类:Medicine 小类:Cancer Research Q2 100 / 230

56%

期刊发文

  • Quantitative analysis of superb microvascular imaging for monitoring tumor response to chemoradiotherapy in locally advanced cervical cancer

    Author: Zhu, Yi; Tang, Yixin; Zhang, Guonan; Zhang, Jie; Li, Yanjie; Jiang, Zhuolin

    Journal: FRONTIERS IN ONCOLOGY. 2023; Vol. 12, Issue , pp. -. DOI: 10.3389/fonc.2022.1074173

  • Uterine cervical Mullerian adenosarcoma possibly arising from ovarian cystadenofibroma: A case report and review of the literature

    Author: Zhu, Xinxin; Peng, Chao; Huang, Yan; Zhou, Yingfang

    Journal: FRONTIERS IN ONCOLOGY. 2023; Vol. 12, Issue , pp. -. DOI: 10.3389/fonc.2022.1064851

  • Metabolic syndrome is a risk factor for breast cancer patients receiving neoadjuvant chemotherapy: A case-control study

    Author: Zhou, Zhaoyue; Zhang, Yue; Li, Yue; Jiang, Cong; Wu, Yang; Shang, Lingmin; Huang, Yuanxi; Cheng, Shaoqiang

    Journal: FRONTIERS IN ONCOLOGY. 2023; Vol. 12, Issue , pp. -. DOI: 10.3389/fonc.2022.1080054

  • Advances in research on the relationship between thymoquinone and pancreatic cancer

    Author: Zhao, Zhanxue; Liu, Linxun; Li, Shuai; Hou, Xiaofan; Yang, Jinyu

    Journal: FRONTIERS IN ONCOLOGY. 2023; Vol. 12, Issue , pp. -. DOI: 10.3389/fonc.2022.1092020

  • A nomogram model to individually predict prognosis for esophageal cancer with synchronous pulmonary metastasis

    Author: Zhang, Xin-yao; Lv, Qi-yuan; Zou, Chang-lin

    Journal: FRONTIERS IN ONCOLOGY. 2023; Vol. 12, Issue , pp. -. DOI: 10.3389/fonc.2022.956738

  • Artificial intelligence applicated in gastric cancer: A bibliometric and visual analysis via CiteSpace

    Author: Zhang, Guoyang; Song, Jingjing; Feng, Zongfeng; Zhao, Wentao; Huang, Pan; Liu, Li; Zhang, Yang; Su, Xufeng; Wu, Yukang; Cao, Yi; Li, Zhengrong; Jie, Zhigang

    Journal: FRONTIERS IN ONCOLOGY. 2023; Vol. 12, Issue , pp. -. DOI: 10.3389/fonc.2022.1075974

  • DEF6 has potential to be a biomarker for cancer prognosis: A pan-cancer analysis

    Author: Yuan, Ziming; Zhong, Yuchen; Hu, Hanqing; Zhang, Weiyuan; Wang, Guiyu

    Journal: FRONTIERS IN ONCOLOGY. 2023; Vol. 12, Issue , pp. -. DOI: 10.3389/fonc.2022.1064376

  • Development and validation of A CT-based radiomics nomogram for prediction of synchronous distant metastasis in clear cell renal cell carcinoma

    Author: Yu, Xinxin; Gao, Lin; Zhang, Shuai; Sun, Cong; Zhang, Juntao; Kang, Bing; Wang, Ximing

    Journal: FRONTIERS IN ONCOLOGY. 2023; Vol. 12, Issue , pp. -. DOI: 10.3389/fonc.2022.1016583